[Chorea, lupus and antiphospholipid antibodies]. / Chorée, lupus et antiphospholipides.
Rev Med Interne
; 33(4): 206-8, 2012 Apr.
Article
en Fr
| MEDLINE
| ID: mdl-22365472
ABSTRACT
Chorea may occur in patients with SLE with a frequency estimated at 1 to 3% in adults and up to 9% in paediatric lupus. Chorea is frequently a presenting feature, and is strongly related to the presence of antiphospholipid antibodies. A treatment with antiplatelet agents and hydroxychloroquine is generally sufficient. During follow-up, the patients with chorea have a significant higher risk to develop thrombotic events (mainly arterial). They also have an excess risk of obstetric morbidity and valvular disease. The prescription of antiplatelet agents and adequate management, especially during pregnancy, can probably reduce this risk.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inhibidores de Agregación Plaquetaria
/
Corea
/
Anticuerpos Antifosfolípidos
/
Hidroxicloroquina
/
Factores Inmunológicos
/
Lupus Eritematoso Sistémico
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Child
/
Humans
País/Región como asunto:
Europa
Idioma:
Fr
Revista:
Rev Med Interne
Año:
2012
Tipo del documento:
Article
País de afiliación:
Francia
Pais de publicación:
FR
/
FRANCE
/
FRANCIA
/
FRANÇA